Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T63816 | Target Info | |||
Target Name | Histone deacetylase 4 (HDAC4) | ||||
Synonyms |
KIAA0288; HD4
Click to Show/Hide
|
||||
Target Type | Clinical trial Target | ||||
Gene Name | HDAC4 | ||||
Biochemical Class | Carbon-nitrogen hydrolase | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Histone deacetylase 1 (HDAC1) | Successful Target | ||||
UniProt ID | HDAC1_HUMAN | |||||
Gene Name | HDAC1 | |||||
Synonyms |
RPD3L1; HD1
Click to Show/Hide
|
|||||
Representative Drug(s) | JNJ-26481585 | Drug Info | Ki = 0.03 nM | [1] | ||
Co-Target Name | Histone deacetylase 2 (HDAC2) | Clinical trial Target | ||||
UniProt ID | HDAC2_HUMAN | |||||
Gene Name | HDAC2 | |||||
Synonyms |
HD2
Click to Show/Hide
|
|||||
Representative Drug(s) | JNJ-26481585 | Drug Info | Ki = 0.06 nM | [1] | ||
Co-Target Name | Histone deacetylase 3 (HDAC3) | Clinical trial Target | ||||
UniProt ID | HDAC3_HUMAN | |||||
Gene Name | HDAC3 | |||||
Synonyms |
SMAP45; RPD32; RPD3-2; HD3
Click to Show/Hide
|
|||||
Representative Drug(s) | JNJ-26481585 | Drug Info | Ki = 2.1 nM | [1] | ||
Co-Target Name | Histone deacetylase 6 (HDAC6) | Clinical trial Target | ||||
UniProt ID | HDAC6_HUMAN | |||||
Gene Name | HDAC6 | |||||
Synonyms |
KIAA0901; JM21; HD6
Click to Show/Hide
|
|||||
Representative Drug(s) | JNJ-26481585 | Drug Info | Ki = 16.9 nM | [1] | ||
Co-Target Name | Histone deacetylase 10 (HDAC10) | Patented-recorded Target | ||||
UniProt ID | HDA10_HUMAN | |||||
Gene Name | HDAC10 | |||||
Synonyms |
Polyamine deacetylase HDAC10; HD10
Click to Show/Hide
|
|||||
Representative Drug(s) | JNJ-26481585 | Drug Info | Ki = 0.05 nM | [1] | ||
Co-Target Name | Histone deacetylase 11 (HDAC11) | Patented-recorded Target | ||||
UniProt ID | HDA11_HUMAN | |||||
Gene Name | HDAC11 | |||||
Synonyms |
HD11
Click to Show/Hide
|
|||||
Representative Drug(s) | JNJ-26481585 | Drug Info | Ki = 0.07 nM | [1] | ||
Co-Target Name | Histone deacetylase 8 (HDAC8) | Patented-recorded Target | ||||
UniProt ID | HDAC8_HUMAN | |||||
Gene Name | HDAC8 | |||||
Synonyms |
Histone deacetylase-8; HDACL1; HD8; CDA07
Click to Show/Hide
|
|||||
Representative Drug(s) | JNJ-26481585 | Drug Info | Ki = 0.5 nM | [1] | ||
Co-Target Name | Histone deacetylase 7 (HDAC7) | Patented-recorded Target | ||||
UniProt ID | HDAC7_HUMAN | |||||
Gene Name | HDAC7 | |||||
Synonyms |
Histone deacetylase 7A; HDAC7A; HD7a; HD7
Click to Show/Hide
|
|||||
Representative Drug(s) | JNJ-26481585 | Drug Info | Ki = 1.7 nM | [2] | ||
Co-Target Name | Histone deacetylase 5 (HDAC5) | Patented-recorded Target | ||||
UniProt ID | HDAC5_HUMAN | |||||
Gene Name | HDAC5 | |||||
Synonyms |
KIAA0600; HD5; Antigen NY-CO-9
Click to Show/Hide
|
|||||
Representative Drug(s) | JNJ-26481585 | Drug Info | Ki = 2.1 nM | [1] | ||
Co-Target Name | Histone deacetylase 9 (HDAC9) | Patented-recorded Target | ||||
UniProt ID | HDAC9_HUMAN | |||||
Gene Name | HDAC9 | |||||
Synonyms |
MITR; MEF2-interacting transcription repressor MITR; KIAA0744; Histone deacetylase-related protein; Histone deacetylase 7B; HDRP; HDAC7B; HDAC7; HD9; HD7b
Click to Show/Hide
|
|||||
Representative Drug(s) | JNJ-26481585 | Drug Info | Ki = 3.8 nM | [1] | ||
Co-Target Name | Histone deacetylase 3-Nuclear receptor corepressor 2 complex (HDAC3-NCOR2) | Co-Target | ||||
UniProt ID | HDAC3_HUMAN-NCOR2_HUMAN | |||||
Gene Name | HDAC3-NCOR2 | |||||
Representative Drug(s) | JNJ-26481585 | Drug Info | IC50 = 4.86 nM | [3] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Evaluation of histone deacetylase inhibitors (HDACi) as therapeutic leads for human African trypanosomiasis (HAT). Bioorg Med Chem. 2015 Aug 15;23(16):5151-5. | ||||
REF 2 | Squaramides as novel class I and IIB histone deacetylase inhibitors for topical treatment of cutaneous t-cell lymphoma. Bioorg Med Chem Lett. 2018 Sep 15;28(17):2985-92. | ||||
REF 3 | Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer's Disease. J Med Chem. 2016 Oct 13;59(19):8967-9004. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.